Alembic Pharmaceuticals gets EIR from USFDA for Panelav facility

05 Oct 2016 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA). The regulator had carried out the inspection at the company's formulation facility located at Panelav in March, 2016.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

840.00 -6.15 (-0.73%)
17-Dec-2025 15:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.95
Dr. Reddys Lab 1271.00
Cipla 1497.45
Zydus Lifesciences 917.85
Lupin 2109.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×